Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sierra Sciences is a private Reno, Nevada biotechnology company focused on extending human lifespan and healthspan through telomere maintenance and telomerase induction. Founded by telomerase researcher William H. Andrews, the company concentrates on discovering compounds and related technologies intended to induce telomerase expression, lengthen telomeres, and counter cellular senescence associated with aging. Its public materials emphasize research rather than commercial drug development, and indicate that affiliated entity Sierra Holdings licenses discovered compounds and technologies to downstream product developers. Sierra Sciences appears to operate primarily as an early-stage longevity biotech and research platform company rather than a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sierra Sciences.